Comparison of the efficacy and safety of 1.5 compared with 3.0 g oral slow-release mesalazine (Pentasa) in the maintenance treatment of ulcerative colitis. Dutch Pentasa Study Group.

Autor:	Fockens, Paul, Mulder, Chris J. J., Tytgat, Guido N. J., Blok, Paul, Ferwerda, Jaap, Fockens, P, Mulder, C J, Tytgat, G N, Blok, P, Ferwerda, J, Meuwissen, S G, Tuynman, H A, Dekker, W, Gasthuis, K, van Hees, P A
Zdroj:	European Journal of Gastroenterology & Hepatology; Nov1995, Vol. 7 Issue 11, p1025-1030, 6p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu